Improving diagnostics and care for first suspected epileptic seizures

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to assess the prevalence of first seizure-like events in Bergen, Norway, and to investigate the clinical trajectory of patients before and after an epilepsy diagnosis. It focuses on individuals who have experienced events suspected to be epileptic seizures, including those who have not yet been evaluated by a neurologist. The study will utilize EEG as a key diagnostic tool, alongside advancements in artificial intelligence to enhance diagnostic accuracy. By establishing a first seizure clinic, the study seeks to improve early diagnostics and alleviate the uncertainty surrounding epilepsy diagnoses.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* The patient has experienced events with a substantial suspicion of being an epileptic seizure. One of:

  * The patient has experienced one or more first-in-life events with a substantial suspicion of being an epileptic seizure, including febrile seizures, and these episodes have previously not been evaluated by a neurologist or pediatrician OR
  * The patient has experienced the recurrence of events with a substantial suspicion of being an epileptic seizure, that have previously been evaluated by a neurologist or pediatrician to not be epileptic, and this merits a new evaluation.
  * OR: The patient does not fulfill the criteria above, but has been investigated for episodes or complaints, which after evaluation have been shown to be first-in-life epileptic seizures.

OR

-The patient has experienced the recurrence of events with a substantial suspicion of being an epileptic seizure, that have previously been evaluated by a neurologist or pediatrician to not be epileptic, and this merits a new evaluation.

Exclusion Criteria:

* Previous known clinical diagnosis of epilepsy given by a neurologist or pediatrician, and not subsequently retracted.
* Person or caregivers able to give informed consent.
* Adequate Norwegian language skills to be able to fill out questionnaires.

Where it's running

• Haukeland University Hospital
  Bergen, Norway Recruiting

Study contacts

• Principal investigator: Jan Brogger, MD PhD — Helse-Bergen HF
• Study coordinator: Jan Brøgger, MD PhD
• Email: jan.brogger@helse-bergen.no
• Phone: 4755975058

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Nicotinamide Riboside by Mouth for Early Alzheimer’s Disease (2-Year Trial)

  This study tests whether taking nicotinamide riboside every day for 24 months can slow progression in adults with early Alzheimer’s disease.

  Recruiting Phase 2 Haukeland University Hospital · Bergen and 1 other locations · NCT07741071

• Effect of a Liberal Fasting Regime on Preoperative Gastric Volume Measured by Ultrasound

  This study tests whether letting adults drink small amounts of clear liquid up to when they’re called for surgery (sip-to-send) is not worse than the standard fasting for keeping the stomach empty before general anesthesia.

  Recruiting Haukeland University Hospital · Bergen, Vestland · NCT07656649

• eCardiacRehab: a home-based, patient-centered cardiac rehab program

  This trial tests a hybrid home-based cardiac rehabilitation program to see if it reduces cardiovascular deaths and ED visits while improving quality of life for adults with CAD after PCI, compared with usual care.

  Recruiting Haukeland University Hospital · Bergen · NCT07590635

• D-SPARK: D‑Serine to modify Parkinson's progression

  This trial will test whether taking D‑serine can slow Parkinson's progression in people diagnosed within five years.

  Recruiting at 3 sites Phase 2 Haukeland University Hospital · Arendal, Agder and 10 other locations · NCT07312110

• Big Five daily actions program adapted for Norway

  This trial will test whether a brief Norwegian program encouraging five daily actions helps people in Norway with mild-to-moderate anxiety or depression compared with a gratitude activity or no treatment.

  Recruiting Haukeland University Hospital · Bergen, Vestland and 1 other locations · NCT07151573

• Behavioral therapy plus GLP-1 medicines for binge eating and weight in people with obesity

  This project will try adding GLP-1 medications to a lifestyle program with CBT-E to see if they reduce binge eating and help adults with obesity lose weight and cope better.

  Recruiting Haukeland University Hospital · Bergen, Vestland · NCT07042672

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.